159 related articles for article (PubMed ID: 32441479)
1. A prospective randomized trial of desmopressin in canine mammary carcinoma.
Sorenmo K; Durham AC; Evans B; Scavello H; Stefanovski D
Vet Comp Oncol; 2020 Dec; 18(4):796-803. PubMed ID: 32441479
[TBL] [Abstract][Full Text] [Related]
2. Effect of adjuvant perioperative desmopressin in locally advanced canine mammary carcinoma and its relation to histologic grade.
Hermo GA; Turic E; Angelico D; Scursoni AM; Gomez DE; Gobello C; Alonso DF
J Am Anim Hosp Assoc; 2011; 47(1):21-7. PubMed ID: 21164169
[TBL] [Abstract][Full Text] [Related]
3. Effect of perioperative desmopressin in cats with mammary carcinoma treated with bilateral mastectomy.
Wood CJ; Chu ML; Selmic LE; Mayhew PD; Holt DE; Martano M; Séguin B; Singh A; Boston SE; Lux C; Liptak JM
Vet Comp Oncol; 2021 Dec; 19(4):724-734. PubMed ID: 32619339
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours.
Pastor N; Ezquerra LJ; Santella M; Caballé NC; Tarazona R; Durán ME
Vet Comp Oncol; 2020 Dec; 18(4):753-762. PubMed ID: 32336005
[TBL] [Abstract][Full Text] [Related]
5. Developing and testing prognostic bio-scoring systems for canine mammary gland carcinomas.
Sorenmo KU; Durham AC; Kristiansen V; Pena L; Goldschmidt MH; Stefanovski D
Vet Comp Oncol; 2019 Dec; 17(4):479-488. PubMed ID: 31099972
[TBL] [Abstract][Full Text] [Related]
6. Response from the authors: A prospective randomized trial of desmopressin in canine mammary carcinoma.
Sorenmo K
Vet Comp Oncol; 2021 Mar; 19(1):5-6. PubMed ID: 32741064
[No Abstract] [Full Text] [Related]
7. Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases.
Rasotto R; Berlato D; Goldschmidt MH; Zappulli V
Vet Pathol; 2017 Jul; 54(4):571-578. PubMed ID: 28355108
[TBL] [Abstract][Full Text] [Related]
8. Desmopressin in canine mammary carcinoma: Comments on the importance of the administration route.
Alonso DF; Turic E; Garona J
Vet Comp Oncol; 2021 Sep; 19(3):409-410. PubMed ID: 32700352
[No Abstract] [Full Text] [Related]
9. Perioperative desmopressin prolongs survival in surgically treated bitches with mammary gland tumours: a pilot study.
Hermo GA; Torres P; Ripoll GV; Scursoni AM; Gomez DE; Alonso DF; Gobello C
Vet J; 2008 Oct; 178(1):103-8. PubMed ID: 17719812
[TBL] [Abstract][Full Text] [Related]
10. Canine malignant mammary gland neoplasms with advanced clinical staging treated with carboplatin and cyclooxygenase inhibitors.
Lavalle GE; De Campos CB; Bertagnolli AC; Cassali GD
In Vivo; 2012; 26(3):375-9. PubMed ID: 22523289
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs.
Marconato L; Lorenzo RM; Abramo F; Ratto A; Zini E
Vet Comp Oncol; 2008 Jun; 6(2):90-101. PubMed ID: 19178668
[TBL] [Abstract][Full Text] [Related]
12. Surgical treatment of mammary carcinomas in dogs with or without postoperative chemotherapy.
Tran CM; Moore AS; Frimberger AE
Vet Comp Oncol; 2016 Sep; 14(3):252-62. PubMed ID: 24735412
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic value of c-met in canine mammary tumours.
Chen YC; Chen YY; Liao JW; Chang SC
Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment.
de M Souza CH; Toledo-Piza E; Amorin R; Barboza A; Tobias KM
Can Vet J; 2009 May; 50(5):506-10. PubMed ID: 19436636
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant post-operative chemotherapy in bitches with mammary cancer.
Karayannopoulou M; Kaldrymidou E; Constantinidis TC; Dessiris A
J Vet Med A Physiol Pathol Clin Med; 2001 Mar; 48(2):85-96. PubMed ID: 11315572
[TBL] [Abstract][Full Text] [Related]
16. Influence of host factors on survival in dogs with malignant mammary gland tumors.
Philibert JC; Snyder PW; Glickman N; Glickman LT; Knapp DW; Waters DJ
J Vet Intern Med; 2003; 17(1):102-6. PubMed ID: 12564734
[TBL] [Abstract][Full Text] [Related]
17. The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours.
Queiroga FL; Pires I; Lobo L; Lopes CS
Res Vet Sci; 2010 Jun; 88(3):441-5. PubMed ID: 19939424
[TBL] [Abstract][Full Text] [Related]
18. Absence of significant adverse events following thalidomide administration in bitches diagnosed with mammary gland carcinomas.
de Campos CB; Lavalle GE; Fialho Ligório S; Camargo Nunes F; Carneiro RA; Amorim RL; Cassali GD
Vet Rec; 2016 Nov; 179(20):514. PubMed ID: 27553604
[TBL] [Abstract][Full Text] [Related]
19. Postoperative treatment outcome in canine mammary tumors. Multivariate analysis of the prognostic value of pre- and postoperatively available information.
Betz D; Schoenrock D; Mischke R; Baumgärtner W; Nolte I
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):235-42. PubMed ID: 22911254
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiles in canine mammary carcinomas of various grades of malignancy.
Pawłowski KM; Maciejewski H; Dolka I; Mol JA; Motyl T; Król M
BMC Vet Res; 2013 Apr; 9():78. PubMed ID: 23587192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
